Announcements Trials
Browse Landscape

Phase

Phase NA 31Phase 3 4Phase 2 2Phase 4 1

Status

Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 1Unresectable Metastatic Colorectal Cancer 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pain, Postoperative 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Nasopharyngeal Carcinoma 1Lymphatic Metastasis 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 149Docetaxel 138Paclitaxel 127Trastuzumab 119Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Control Groups × Clear all
NCT05063136 2024-11-04

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Henan Cancer Hospital

Phase 3 Recruiting
1,979 enrolled
Breast

Breast Neoplasms

NCT04385433 2023-08-24

PRAVAPREV-01

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Terminated
15 enrolled
Breast

Breast Neoplasms

NCT03971019 2019-08-14

SBSBC

Peking Union Medical College Hospital

Phase 3 Unknown
314 enrolled
Breast

Breast Neoplasms

NCT00582244 2007-12-28

EVA project

The Netherlands Cancer Institute

Phase 3 Unknown
325 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡